Skip to main content
Kyriakie Sarafoglou, MD, Pediatric Endocrinology, Minneapolis, MN, M Health Fairview University of Minnesota Medical Center

KyriakieSarafoglouMD

Pediatric Endocrinology Minneapolis, MN

Pediatric Adrenal Endocrinology, Pediatric Bone Metabolism Disorders, Sex Differentiation Endocrinology

Professor, Pediatrics, University of Minnesota Medical School

Dr. Sarafoglou is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sarafoglou's full profile

Already have an account?

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Pediatrics, 1996 - 1999
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Endocrinology, 1990 - 1994
  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Pediatrics, 1987 - 1990
  • University of Athens
    University of AthensClass of 1984

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 1993 - Present
  • MN State Medical License
    MN State Medical License 2005 - 2024
  • NY State Medical License
    NY State Medical License 1996 - 2006
  • American Board of Pediatrics Pediatric Endocrinology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Adrenoleukodystrophy: Guidance for Adrenal Surveillance in Males Identified by Newborn Screen  
    Takara L Stanley, Kyriakie Sarafoglou, Rose Marino, Manmohan Kamboj, Bradley S Miller, The Journal of Clinical Endocrinology and Metabolism

Lectures

  • Adrenal Tumors and Hyperplasia 
    ENDO 2019 - New Orleans, LA - 3/24/2019

Press Mentions

  • Glycomine’s Natural History Study Informs Potentially Lifesaving Update to Standard of Care for PMM2-CDG Patients
    Glycomine’s Natural History Study Informs Potentially Lifesaving Update to Standard of Care for PMM2-CDG PatientsJune 29th, 2021
  • Spruce Biosciences Announces Publication of Phase 2 Results for Tildacerfont in Journal of Clinical Endocrinology and Metabolism
    Spruce Biosciences Announces Publication of Phase 2 Results for Tildacerfont in Journal of Clinical Endocrinology and MetabolismJune 21st, 2021
  • Neurocrine Biosciences Announces Phase 3 Pediatric Study Results of Crinecerfont in Children and Adolescents for the Treatment of Congenital Adrenal Hyperplasia Met Primary and Key Secondary Endpoints
    Neurocrine Biosciences Announces Phase 3 Pediatric Study Results of Crinecerfont in Children and Adolescents for the Treatment of Congenital Adrenal Hyperplasia Met Primary and Key Secondary EndpointsOctober 6th, 2023

Grant Support

  • Partial Growth Hormone Insensitivity In Idiopathic Short Stature/Small-For-GestaNational Center For Research Resources2006–2009
  • Comparison 17-Ohp Measured By Tandem Mass Spectroscopy VS Blood Serum In CAH PANational Center For Research Resources2008
  • Aromatase Inhibitor In Males With Adrenal HyperplasiaEunice Kennedy Shriver National Institute Of Child Health &Human Development2004–2006

Professional Memberships

Hospital Affiliations